𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In Vivo13C NMR spectroscopy of glucose metabolism of RIF-1 tumors

✍ Scribed by Ioannis Constantinidis; John C. Chatham; Janna P. Wehrle; Jerry D. Glickson


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
611 KB
Volume
20
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

An efficient method for measuring in vivo ^13^C NMR spectra of tumors has been developed and employed to monitor glucose metabolism in radiation‐induced fibrosarcomas (RIF‐1) subcutaneously implanted in C3H/HeN mice. [1‐^13^C]Glucose was injected directly into the tumors at a dose of 1 g/kg body wt. Spectra were obtained with a Bruker AM 360‐WB spectrometer (8.4 T/8.9 cm bore) employing a homebuilt probe equipped with a four‐turn solenoidal coil (1.5 cm outer diameter) for detection of ^13^C signals and a Helmholtz coil (two 3‐cm turns separated by a 3‐cm gap, oriented orthogonally to the ^13^C coil) for ^1^H decoupling. In addition to the natural abundance ^13^C resonances of the tumors, signals were detected from the α‐and β‐anomers of labeled glucose. Within 15 min following injection of labeled glucose [3‐^13^C]lactate and [3‐^13^C]alanine were detected. Lactate labeling approached steady state levels within about 50 min after glucose injection; in contrast, alanine labeling increased continuously over the duration of the experiment (70 min). Sixty minutes after glucose injection, the ratio of the intensity of [3‐ ^13^C]lactate to the principal lipid methylene resonance (30 ppm from external tetramethylsilane), which served as an internal intensity reference, was correlated with tumor size, whereas the corresponding ratio of the [3‐ ^13^C] alanine resonance was not. Labeling of glutamate was below the level of detection in the in vivo spectra; however, labeling of C~4~‐glutamate at a level approximately 50‐fold lower than the level of [3‐ ^13^C]lactate was detected in perchloric acid extracts. Incorporation of ^13^C label into C~2~‐and C~3~‐glutamate and C~2~‐lactate was also observed. © 1991 Academic Press, Inc.


📜 SIMILAR VOLUMES


Glucose metabolism in RIF-1 tumors after
✍ Zaver M. Bhujwalla; Dikoma C. Shungu; John C. Chatham; Janna P. Wehrle; Jerry D. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

## Abstract Low pH appears to enhance the effectiveness of therapeutic hyperthermia. ^13^C and ^31^P NMR spectroscopy have been employed to examine the possibility that elevating glucose in a solid tumor while simultaneously reducing tumor blood flow would induce a more profound acidosis than eithe

Detection of [1,6-13C2]-glucose metaboli
✍ Robin A. de Graaf; Peter B. Brown; Graeme F. Mason; Douglas L. Rothman; Kevin L. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

## Abstract Localized, water‐suppressed ^1^H‐[^13^C]‐NMR spectroscopy was used to detect ^13^C‐label accumulation in cerebral metabolites following the intravenous infusion of [1,6‐^13^C~2~]‐glucose (Glc). The ^1^H‐[^13^C]‐NMR method, based on adiabatic RF pulses, 3D image‐selected in vivo spectros

A method for measuring cerebral glucose
✍ David M. Cohen; Jingna Wei; E. O'Brian Smith; Xiaolian Gao; Michael J. Quast; Lo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Current methods for estimating the rate of cerebral glucose utilization (CMR(glc)) typically measure metabolic activity for 40 min or longer subsequent to administration of [(13)C]glucose, 2-[(14)C]deoxyglucose, or 2-[(18)F]deoxyglucose. We report preliminary findings on estimating CMR(glc) for a pe